BA
SLXP

BlackRock Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BlackRock Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,366
Closed -$1.62M – 3822
2015
Q1 		$1.62M Sell
9,366
-152,153
-94% -$22.3M ﹤0.01% 1315
2014
Q4 		$18.6M Buy
161,519
+5,013
+3% +$607K 0.02% 576
2014
Q3 		$24.5M Sell
156,506
-306,772
-66% -$44.5M 0.02% 517
2014
Q2 		$57.1M Buy
463,278
+453,467
+4,622% +$50.1M 0.05% 326
2014
Q1 		$1.02M Buy
9,811
+512
+6% +$52.4K ﹤0.01% 1517
2013
Q4 		$836K Buy
9,299
+733
+9% +$58.5K ﹤0.01% 1640
2013
Q3 		$573K Buy
8,566
+1,254
+17% +$86.4K ﹤0.01% 1812
2013
Q2 		$484K Buy
+7,312
New +$418K ﹤0.01% 1852

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BlackRock Advisors's SLXP Position: Q2 2015 in Review

BlackRock Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 9,366 shares — an estimated $1.62M sold.

BlackRock Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $57.1M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • BlackRock Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • BlackRock Advisors sold 9,366 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.62M.
  • BlackRock Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • BlackRock Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $57.1M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BlackRock Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.